Intestinal bypass and urine oxalate. Golper TA, Harris HF, Houghton DC (1979) Ann Intern Med 91: 129-30 Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA (2005) Kidney Int 67: 53-60 Quiz page. Diabetic nephropathy and extensive, superimposed, intratubular, calcium oxalate crystals, due to enteric hyperoxaluria. Fogo AB (2002) Am J Kidney Dis 40: xl AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Kaushal N, Elliott M, Robson MJ, Iyer AK, Rojanasakul Y, Coop A, Matsumoto RR (2012) Mol Pharmacol 81: 299-308 Focused ultrasound to expel calculi from the kidney: safety and efficacy of a clinical prototype device. Harper JD, Sorensen MD, Cunitz BW, Wang YN, Simon JC, Starr F, Paun M, Dunmire B, Liggitt HD, Evan AP, McAteer JA, Hsi RS, Bailey MR (2013) J Urol 190: 1090-5 Use of the Acoustic Shadow Width to Determine Kidney Stone Size with Ultrasound. Dunmire B, Harper JD, Cunitz BW, Lee FC, Hsi R, Liu Z, Bailey MR, Sorensen MD (2016) J Urol 195: 171-7 A Spectrum: Nephrocalcinosis-Nephrolithiasis. Hsi RS, Stoller ML (2015) J Urol 194: 1188-9 Ethylene glycol toxicity associated with ischemia, perforation, and colonic oxalate crystal deposition. Gardner TB, Manning HL, Beelen AP, Cimis RJ, Cates JM, Lewis LD (2004) J Clin Gastroenterol 38: 435-9 σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Robson MJ, Seminerio MJ, McCurdy CR, Coop A, Matsumoto RR (2013) Pharmacol Rep 65: 343-9 Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Scheinman JI, Voziyan PA, Belmont JM, Chetyrkin SV, Kim D, Hudson BG (2005) Urol Res 33: 368-71
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.